Botulinum toxin is one of the most potent biological substances known to science, yet it has become a fixture in dermatology offices, neurology clinics, and urology suites worldwide. The same molecule that causes botulism, a paralytic foodborne illness, is purified, diluted, and injected in microscopic doses to relax overactive muscles and quiet overactive nerves. Marketed under brand names such as Botox, Dysport, Xeomin, Jeuveau, Daxxify, and Letybo, botulinum toxin is technically a large protein neurotoxin, not a small peptide, but it sits alongside peptide therapeutics because both act on the body's signaling machinery. This guide explains how botulinum toxin works, what it is FDA-approved to treat, how the major brands compare, realistic dosing and duration, the full safety picture, and why buying it online to inject yourself can be life-threatening.[1]
🔑 Key Takeaways
- Botulinum toxin works by cleaving SNAP-25, a SNARE protein, which blocks acetylcholine release at the nerve-muscle junction and temporarily relaxes the targeted muscle.[1]
- It is FDA-approved for far more than wrinkles: chronic migraine, cervical dystonia, blepharospasm, strabismus, overactive bladder, severe underarm sweating, and limb spasticity.[1][2]
- Six type A brands (Botox, Dysport, Xeomin, Jeuveau, Daxxify, Letybo) and one type B (Myobloc) are available in the US, but their units are not interchangeable.[2][3]
- Cosmetic results take roughly two weeks to fully appear and last about 3 to 4 months; Daxxify can last 6 months in many patients.[1][6]
- Buying botulinum toxin online and self-injecting has caused hospitalizations and iatrogenic botulism; in 2025 the CDC documented three women who needed antitoxin after injecting counterfeit product.[7][8]
What Is Botulinum Toxin?
Botulinum toxin (often abbreviated BoNT) is a neurotoxic protein produced by the anaerobic bacterium Clostridium botulinum and a few related species. Seven distinct serotypes exist, labeled A through G, but only four products are clinically prepared for human use: three forms of serotype A and one of serotype B.[1] In its natural, ingested form the toxin causes botulism, a potentially fatal paralytic illness. In medicine, the purified toxin is measured in tiny biological "units" and injected in amounts thousands of times below the lethal range, which is what makes controlled, localized muscle relaxation possible without systemic poisoning.[1]
Strictly speaking, botulinum toxin is a large protein (roughly 150 kilodaltons) made of a heavy chain and a light chain, so it is much bigger than the short cosmetic and therapeutic peptides discussed elsewhere on this site. It still belongs to the broader conversation about biological signaling molecules because, like many peptides, it achieves its effect by interrupting a specific protein-protein interaction inside the nerve terminal. If you are looking for non-injected, peptide-based alternatives that aim to mimic part of this muscle-relaxing effect topically, see our overview of anti-wrinkle peptides and the dedicated Argireline peptide guide.
How Does Botulinum Toxin Work? (Mechanism of Action)
Normally, when a nerve signals a muscle to contract, the nerve terminal releases the neurotransmitter acetylcholine into the synapse. That release depends on a set of "SNARE" proteins that pull the acetylcholine-filled vesicle up to the cell membrane so it can fuse and dump its contents.[1]
Botulinum toxin interrupts this process in four steps:[1]
- Binding. The heavy chain anchors the toxin to specific receptors and gangliosides on the cholinergic nerve terminal.
- Internalization. The toxin is taken into the nerve cell by endocytosis, packaged inside a vesicle.
- Translocation. The light chain is released from the vesicle into the cell's interior (cytosol).
- Cleavage. The light chain acts as a zinc-dependent protease and cuts SNAP-25 (for type A products) or VAMP/synaptobrevin (for type B). The damaged SNARE complex can no longer fuse the vesicle, so acetylcholine cannot be released.
With acetylcholine release blocked, the muscle (or sweat gland, or bladder muscle) receives no "contract" signal and relaxes. The effect is temporary because the nerve eventually sprouts new terminals and regenerates functional SNARE proteins, which is why injections need to be repeated.[1] Type A toxins cleave SNAP-25; type B (Myobloc) cleaves a different SNARE protein, which partly explains why the two types are dosed completely differently and are not interchangeable.[2]
Why "units" are not interchangeable between brands
A unit of botulinum toxin is a measure of biological activity, defined historically by a mouse-based potency assay, and each manufacturer sets its own reference standard. As a result, 1 unit of Botox does not equal 1 unit of Dysport or 1 unit of Myobloc. Clinicians who switch a patient between brands recalculate the dose using brand-specific conversion experience, never a simple 1-to-1 swap.[2][3]
FDA-Approved Uses of Botulinum Toxin
Most people associate botulinum toxin with frown lines, but the cosmetic indication is only one of many. Across the approved products, FDA-cleared therapeutic and aesthetic uses include:[1][2]
- Chronic migraine (15 or more headache days per month) as preventive treatment.
- Cervical dystonia (painful, abnormal neck posturing).
- Blepharospasm (involuntary eyelid spasm) and strabismus (eye misalignment).
- Upper and lower limb spasticity, including in pediatric patients.
- Overactive bladder and neurogenic detrusor overactivity.
- Severe primary axillary hyperhidrosis (excessive underarm sweating).
- Glabellar (frown) lines, and for some brands lateral canthal (crow's feet) and forehead lines.
Not every brand carries every indication. Botox holds the broadest label and is the only product FDA-approved specifically to prevent chronic migraine, while several newer brands (Jeuveau, Letybo) are currently approved for glabellar lines only.[2][9] The autonomic and cosmetic effects of toxin on sweat glands also explain why it is studied for conditions involving acetylcholine-driven gland activity, a different target than the collagen-stimulating skin peptides used for texture and firmness.
Botox vs Dysport vs Xeomin vs Jeuveau vs Daxxify vs Letybo
All six widely used US brands are botulinum toxin type A, but they differ in formulation, onset, duration, spread, and approved uses. The table below synthesizes the generic names, approval focus, and practical characteristics most often cited in clinical comparisons. Doses are illustrative for the glabellar (frown line) area and should never be self-applied.
Daxxify is the standout on duration. Its approval rested on the SAKURA phase 3 program of more than 2,700 patients, in which the median duration of effect was about 6 months, with results lasting as long as 9 months in some patients, considerably longer than the roughly 3 to 4 months typical of the other brands.[6] Letybo, approved in February 2024 based on the BLESS I-III trials in 1,271 patients, became the sixth FDA-approved neurotoxin and is currently indicated for glabellar lines only.[9]
How Effective Is Botulinum Toxin? Real Numbers
For frown lines, the evidence is robust. In a meta-analysis of four phase 3 trials, 84.2 percent of 621 patients treated with 20 units of onabotulinumtoxinA were rated as responders at day 30 on the Facial Wrinkle Scale.[4] In a separate randomized placebo-controlled trial, 82.8 percent of the 20-unit group were responders at day 30 versus only 4.2 percent on placebo, and meaningful benefit was sustained for about 4 months in more than half of responders.[5]
For chronic migraine, the pivotal PREEMPT program of 1,384 patients used the standardized 155-unit protocol delivered across 31 injection sites in seven head and neck muscle groups. Treated patients had a significantly greater reduction in headache days than placebo at the 24-week endpoint (roughly 7.8 and 9.2 fewer days in the two studies, versus about 6.4 and 6.9 with placebo).[10] That difference is the basis for Botox being the only FDA-approved preventive specifically for chronic migraine.[10]
Onset, Duration, and What to Expect
Botulinum toxin does not work instantly. Cosmetic effects begin within a few days and take roughly two weeks to fully develop, then last about three to five months for aesthetic use and as long as six to nine months for some autonomic (for example, sweating) applications.[1] As the toxin wears off, muscle movement gradually returns and lines or symptoms come back, which is why maintenance treatments are scheduled every few months. Because the body slowly forms new nerve terminals, the effect is inherently reversible and temporary.[1]
Effect size in real terms
The placebo-adjusted benefit matters more than the raw response rate. In glabellar-line trials, about 83 percent of people responded to 20 units versus about 4 percent on placebo, an absolute gap near 79 percentage points.[4][5] For chronic migraine, treated patients lost roughly 1.4 to 2.3 more headache days per month than placebo at week 24, a difference that adds up to roughly 17 to 28 fewer headache days a year for a frequent sufferer.[10]
Cost of Botulinum Toxin in 2025
Cosmetic botulinum toxin is almost always priced per unit. In 2025, the typical US price ran about $10 to $25 per unit depending on region, brand, and injector, with metropolitan and coastal markets at the higher end.[11] Because the labeled glabellar dose is 20 units, a frown-line treatment commonly lands in the $200 to $375 range, and a full upper-face session (forehead plus frown lines plus crow's feet) often totals $350 to $900.[11] The table below puts common cosmetic areas into perspective; actual units vary widely by anatomy and goals.
Therapeutic uses such as chronic migraine, cervical dystonia, or overactive bladder are frequently covered by medical insurance when criteria are met, unlike purely cosmetic treatments, which are paid out of pocket.[10]
Side Effects and Safety
The most common adverse effects are local and short-lived: injection-site pain, bruising, swelling, headache, and temporary eyelid droop (ptosis) when the toxin migrates to nearby muscles.[1] More serious problems are uncommon when product is genuine and injected correctly, but the FDA-mandated boxed warning applies to all botulinum toxin products: the effect can spread beyond the injection site, causing symptoms such as muscle weakness, double vision, drooping eyelids, trouble swallowing or speaking, and in rare cases life-threatening breathing difficulty. These can appear hours to weeks after injection.[1]
Botulinum toxin is generally avoided in people with certain neuromuscular disorders (for example, myasthenia gravis or Lambert-Eaton syndrome), known allergy to the toxin, active infection at the injection site, and during pregnancy or breastfeeding.[1] Anyone who develops swallowing, speaking, or breathing trouble after an injection should seek emergency care immediately and not wait, because these can signal distant spread or botulism.[8]
Myth vs Fact
The Danger of DIY and Counterfeit Botulinum Toxin
The single most important safety message about botulinum toxin in 2025 and 2026 is this: it is not a do-it-yourself product. In May and June 2025, the CDC documented three women (ages 29, 50, and 59) in New York, Texas, and Wisconsin who developed severe neurological symptoms after self-injecting botulinum toxin they bought online from unlicensed overseas vendors. All three experienced difficulty swallowing, slurred speech, drooping eyelids, and arm weakness; one needed mechanical ventilation, and all three were hospitalized for 3 to 6 days and received heptavalent botulism antitoxin.[7] None had a medical license or injector training, and the products were presumed counterfeit or unlicensed.[7]
Regulators have acted on the supply side too. In November 2025 the FDA issued a warning letter to an online seller marketing unapproved botulinum toxin products to US consumers, reinforcing that these products are not FDA-cleared and that purchasing them is unsafe.[12] The CDC and FDA guidance is unambiguous: botulinum toxin should only be administered by licensed, trained medical professionals using recommended doses of FDA-approved products bought directly from the manufacturer or an authorized distributor.[7][8] "Iatrogenic" botulism, the kind that results from injecting too much toxin or counterfeit toxin, is a medical emergency that can cause paralysis and death if untreated.[8]
Who should and should not consider botulinum toxin
Reasonable candidates: adults seeking treatment for an FDA-approved condition or cosmetic concern, treated by a licensed clinician using genuine product. Should avoid or use caution: people with neuromuscular disorders such as myasthenia gravis, known toxin allergy, active infection at the site, those who are pregnant or breastfeeding, and anyone considering buying or injecting the toxin themselves. The decision and the dose should always be made with a qualified medical professional, never from an online tutorial.[1][7][8]
Frequently Asked Questions
The Bottom Line
Botulinum toxin is a uniquely powerful tool that turns one of nature's deadliest poisons into a precise, reversible way to relax muscles and quiet overactive nerves. It is well-studied, FDA-approved for a long list of cosmetic and medical conditions, and effective: roughly 83 percent of people respond to a standard frown-line dose, and chronic migraine sufferers can lose dozens of headache days a year.[4][5][10] The catch is that its power is exactly why it must be handled by professionals. The difference between a therapeutic dose and a dangerous one is small, units are not standardized across brands, and counterfeit product bought online has already put people in the hospital. If you are considering botulinum toxin, work with a licensed clinician and genuine, FDA-approved product. To compare the non-injected, peptide-based options for skin, explore our guides to the best peptides for skin and the foundations in what peptides are.
References
- Padda IS, Tadi P. Botulinum Toxin. StatPearls, NCBI Bookshelf (NBK557387).
- U.S. Food and Drug Administration. Drug Trials Snapshots: LETYBO (and overview of approved botulinum toxin products).
- Botulinum toxin: serotypes, SNAP-25 mechanism, and approved products (overview).
- Efficacy and Safety of Botulinum Toxin Type A for Glabellar Lines: A Meta-Analysis of Randomized, Placebo-Controlled, Double-Blind Trials. PubMed PMID 26313835.
- Safety, Pharmacodynamic Response, and Treatment Satisfaction With OnabotulinumtoxinA in Dynamic Glabellar Lines. PMC9558451.
- DaxibotulinumtoxinA-lanm (Daxxify): SAKURA program and duration of effect. Skin Therapy Letter.
- CDC MMWR Notes From the Field: Severe Illnesses After Self-Injection of Botulinum Toxin Purchased Online, New York, Texas, and Wisconsin, 2025. PMC12654868.
- Centers for Disease Control and Prevention. About Botulism (including iatrogenic botulism).
- Letybo (letibotulinumtoxinA-wlbg) FDA Approval History, February 29, 2024. Drugs.com.
- BOTOX (onabotulinumtoxinA) FDA Approved for Chronic Migraine: PREEMPT trial results.
- GoodRx. How Much Does Botox Cost? Per-unit and per-treatment pricing (2025).
- U.S. Food and Drug Administration. Warning Letter: Glowface, November 3, 2025 (unapproved botulinum toxin products).